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Abstract
Label quality is an important and common problem
in contemporary supervised machine learning research.
Mislabeled instances in a data set might not only impact
the performance of machine learning models negatively
but also make it more difficult to explain, and thus trust,
the predictions of those models. While extant research
has especially focused on the ex-ante improvement
of label quality by proposing improvements to the
labeling process, more recent research has started
to investigate the use of machine learning-based
approaches to identify mislabeled instances in training
data sets automatically. In this study, we propose
a two-staged pipeline for the automatic detection of
potentially mislabeled instances in a large medical data
set. Our results show that our pipeline successfully
detects mislabeled instances, helping us to identify 7.4%
of mislabeled instances of Cardiomegaly in the data
set. With our research, we contribute to ongoing efforts
regarding data quality in machine learning.

1.

Introduction

Machine learning (ML) models can increasingly
match or outperform humans at various tasks in diverse
application domains. Contemporary ML models have,
for example, been shown to identify lung diseases
on chest X-rays more accurately than radiologists
[1], or beat experienced players in notoriously
difficult-to-master games [2]. Next to algorithmic
advances, another fundamental reason for the recent
progress in ML is the growing availability of training
data [3], which is driven by the accelerating digitization
of nearly all aspects of our everyday lives. This
increasing availability of training data, however, is often
contrasted by quality deficiencies of the data sets [4].
Especially when training data has to be labeled for
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supervised ML tasks, label quality is a common problem
(i.e., instances are often mislabeled), as training data are
mostly still labeled by hand [5]. Not only is such manual
labeling of large data sets costly and time-consuming,
but also error-prone [6].
Eventually, poor-quality training data might not only
affect ML model performance negatively [6, 7], but
also make post-hoc explainability and, therefore, trust
in such ML models’ predictions more difficult to attain,
and may even inhibit the adoption of ML in information
systems [8]. The problem of mislabeled instances
in training data is further aggravated where expert
knowledge is required to label data. Particularly in the
medical field, one of the most promising domains for the
application of ML [9], poor label quality is an immense
problem [10]. On the one hand, medical experts are
scarce, expensive, and their limited time is better spent
on other tasks (e.g., treating patients) than on identifying
mislabeled instances or labeling instances, to begin with
[10]. On the other hand, the consequences of poorly
labeled data and, thus, poorly performing ML models
can be especially severe. They might negatively impact
patients’ health, such as misclassification of disease
[11], enforce biases [12], or disadvantage the poor [13].
Extant research has dealt extensively with label
quality in the context of supervised ML. In the
past, researchers have especially focused on the
ex-ante improvement of label quality by proposing
improvements to the labeling process (cf. Section 2.1).
More recently, researchers have also begun investigating
means for the ex-post improvement of label quality,
such as training ML models on the respective data
sets and classifying instances in the data set with this
trained model in order to identify mislabeled instances
in training data sets automatically [5]. While such
approaches generalize well across different data sets
[5], they are usually inconsiderate of the specific
characteristics of different data sets (e.g., the degree
of confidence for an individual instance’s label, or the
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temporal dimension of a data set in which multiple
instances exist for one patient). We, therefore, ask the
following research question:
RQ: How can we improve label quality in medical
data sets ex-post by means of using ML to detect
potentially mislabeled instances?
To answer our research question, we build on recent
research for the ML-based detection of mislabeled
instances and propose a two-staged pipeline for
the identification of mislabeled instances that, in
addition, takes advantage of salient characteristics of
the underlying data set. Specifically, we focus on
the CheXpert data set (see Section 2.2 for a detailed
description of the data set) and make use of—what we
call—explicitly and implicitly labeled data instances,
as well as the fact that the data set contains a
temporal dimension (i.e., providing multiple instances
for the same patient at different points in time) to
better detect potentially mislabeled instances. In doing
so, we provide a two-fold contribution. First, we
propose a novel method that combines an ML approach
in form of a convolutional neural network with a
data set-specific heuristic to improve the detection
of potentially mislabeled instances. Applying our
method can improve the explainability and, thus, the
trustworthiness of ML-based information systems [14].
Second, we directly contribute to the CheXpert data
set by identifying potentially mislabeled instances of
Cardiomegaly in the data set.
The remainder of this paper is organized as follows.
In the next section, we briefly summarize the related
research on improving label quality in supervised ML
and describe the CheXpert data set that we use for
our analysis. Afterward, we summarize our proposed,
two-staged pipeline in section three, before we describe
the first stage in more detail in section four, and the
second stage in more detail in section five. We discuss
our results in section six and conclude this paper with
section seven.

2.
2.1.

Background
Data labeling and label quality

When data instances are acquired (e.g., images using
a camera), they are usually unlabeled. In order for
acquired data instances to be usable for supervised ML,
they must be annotated first (i.e., one or several labels
must be assigned to each instance). Although there
exist approaches for the automatic extraction of labels
(e.g., through rule-based natural language processing),
most annotation tasks are either completely or at least
partially performed by humans today [21]. Simple

annotation tasks, for example, are often crowdsourced
through platforms like Amazon’s Mechanical Turk [22],
whereas more complex annotation tasks are outsourced
to dedicated teams in low-income countries [21, 23].
Yet, the manual annotation of large data sets is costly,
time-consuming, and error-prone [6]. Typical sources
of error in the annotation process include subjectivity,
data-entry error, or inadequate information [6].
Extant research has dealt extensively with label
quality in the context of supervised ML. Toward
this end, researchers have especially focused on the
ex-ante improvement of label quality by proposing
improvements to the annotation process (sectors A and
B in Table 1). Such approaches typically generalize
well across different types of data sets for different
industries, or are developed specifically for one type
of data set in a specific industry. An example for a
method that generalizes well across different types of
data sets and industries is an annotator rating system that
aims to maximize the label quality while minimizing the
number of annotators required [15, 16, 17]. An example
of a method specifically developed for one industry is
the usage of citizen scientists to annotate bird images
[24]. In the health care industry, approaches deal with
a wide range of specific issues such as training data
[18], image classification tasks [19] or reference data
generation [20]. The majority of these approaches use
crowdsourcing and a recent overview of the usage of
crowdsourcing in medical image analysis is provided by
Ørting et al. [25].
Alternatively, researchers have started to investigate
ML-based approaches for the ex-post identification of
mislabeled instances after these instances have been
(incorrectly) annotated already (sectors C and D in Table
1) [5, 6, 7]. Again, the majority of contemporary
approaches generalize well across different data sets for
different industries, for example, by training an ML
model on the labeled data set and reclassifying the
instances of the same data set, which uncovers potential
label errors [5]. In contrast, we develop our approach
specifically for the peculiarities of the CheXpert data
set as a representative in the medical imaging industry,
which especially includes the presence of explicit and
implicit labels, as well as a temporal dimension in the
data set as described in Section 2.2.

2.2.

The CheXpert data set

Medical imaging is one of the major application
domains for supervised ML [10], with chest X-rays
being the most common medical image diagnostic
worldwide today [26]. Medical imaging is also a domain
in which mislabeled instances can have particularly
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severe consequences. Accordingly, we decided to focus
on the medical imaging domain in this paper and draw
on the CheXpert data set to develop a system pipeline
for the identification of potentially mislabeled instances
in large ML data sets [27]. In the following, we provide
a brief description of the data set.
The CheXpert data set was compiled by a
Stanford-based research group led by Jeremy Irvin and
Pranav Rajpurkar. It contains 224,316 instances of
chest X-rays, 85% of which are frontal scans, while the
remaining 15% are lateral scans. Each instance in the
data set has a variety of corresponding labels, including
a patient ID (total: 65,240 patients), patient age and sex,
and 14 labels that represent clinical observations (i.e.,
no finding, support devices such as pacemakers, and 12
medical conditions such as fractures, pleural effusion or
Cardiomegaly) of a given X-ray scan. For each instance
in the data set, each of these 14 labels contains either a 1
(i.e., the clinical observation corresponding to that label
is present in that scan), a 0 (i.e., the clinical observation
corresponding to that label is not present in that scan),
a -1 (i.e., there is no clear indication of the presence
or absence of the corresponding disease in that scan),
or NaN (i.e., there is no information available about
the corresponding clinical observation for that scan).
Further on, to provide a mapping between the scans and
the corresponding labels, a path label, which assigns a
unique scan to each instance in the data set, is included.
It is noteworthy that labels for the 14 clinical
observations were constructed using rule-based natural
language processing algorithms, which extracted
relevant information out of radiologists’ reports. NaN,
therefore, has a dual meaning. Either the radiologists
did not investigate this observation due to a clear lack

of its presence, or the rule-based natural language
processing algorithms were unable to identify or
translate the aspect in the respective report. In both
cases, a thorough investigation of label correctness
should result in an improved label quality.
Several studies have made use of the CheXpert data
set. This includes, for example, studies testing different
approaches toward explainable artificial intelligence
in radiology [28], studies aiming to detect multiple
diseases on a single X-ray scan [29], or studies
analyzing the computational efficiency and accuracy
of different neural network architectures for radiology
[30]. Furthermore, recent studies create COVID-19
disease detectors on chest X-ray scans and use the
CheXpert data set to obtain negative instances [31] or
for pre-training [32].

3.

Pipeline overview

In order to detect potentially mislabeled instances in
the CheXpert data set, we propose a two-stage pipeline
(see Figure 1). Within the first stage, and similar to
Müller and Markert [5], we develop an ML approach,
where we train a neural network on a high-quality
subset of the main data set (i.e., the CheXpert data
set) and then use the resulting ML model to reclassify
instances in a test subset. Within the second stage,
we develop a heuristic approach that builds on the
results of the reclassification and applies additional, data
set-specific criteria to identify potentially mislabeled
instances more accurately. The ultimate objective of
the heuristic approach is to further minimize error rates
when identifying mislabeled instances.

Table 1: Overview of extant research streams.

Approach
Improve annotation process (ex-ante label
Identify mislabeled instances (ex-post label
quality improvement)
quality improvement)

General

[A] Typical RQ: How to efficiently use
human annotators?

Industry

Example study: [15, 16, 17]

Specific

[B] Typical RQ: How can multiple
annotations be applied to assure highly
reliable reference correspondences for
endoscopic image?
Example study: [18, 19, 20]

[C] Typical RQ: How to identify mislabelled
instances in a data set?
Example study: [5, 6, 7]
[D] RQ: How can we improve label quality
in medical data sets ex-post by means
of using ML to detect potentially
mislabeled instances?
This study.
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4.

Machine learning approach

4.1.

The first stage of our pipeline consists of an
ML-based approach that we illustrate in Figure 2. The
grey highlighted areas represent all steps where we
handle explicit data whilst white cells use implicit and
explicit data as well. Within the approach, we train
an ML model on a high-quality subset of the main
data set and then use the resulting model to re-classify
our testing data. If the re-classification result deviates
from the instance’s original label, we consider it as an
indication for a mislabeled instance and further process
this instance in stage two. In the following, we describe
our ML approach and its outputs in more detail.

Figure 1: Overview of the proposed two-staged pipeline.

To decrease the likelihood that our ML model makes
an error, we need to train it on data instances with
high-quality labels. Accordingly, we introduce the
distinction between explicitly and implicitly labeled
instances. For a certain condition, each data instance
is either explicitly labeled or implicitly labeled. For an
instance to be explicitly labeled for a given condition,
the condition needs to be mentioned in the radiologists’
reports, assuming a value of -1 (no clear indication),
0 (condition not present), or 1 (condition present). In
contrast, if there was no information on that specific
condition in the radiologists’ reports at all (i.e., the
instance has a NaN label for that condition), it is
considered implicitly labeled. Table 2 illustrates the
distribution of implicitly and explicitly labeled instances
in the CheXpert data set.
Out of the 14 different conditions in the CheXpert
data set, we focus on the Cardiomegaly condition,
which describes an enlargement of the heart. We do
so for multiple reasons. First, Cardiomegaly has a
high clinical importance with a prevalence of nearly
5.8 million people in the United States alone [33].
Second, it is also one of the five observations selected
for the CheXpert competition tasks [27]. Third, among
the competition tasks, Cardiomegaly has the highest
percentage of implicit labels with 79.32%, thus, having
great potential for improvement. Accordingly, the final
instance labels for this study consist of path, age,
patient ID and cardiomegaly.
Before we can build and deploy our ML-based
approach, we need to create different subsets out of
our data set. For this, we group the X-ray scans on a
per-patient basis. This ensures that each patient only
occurs in one subset. We further filter out lateral
scans, which leaves us with frontal scans, representing
the majority of instances in the CheXpert data set
(n = 191,027). We apply the common 70:30-split
for machine learning algorithms, resulting in 133,718
frontal scans in the training data set and 57,309 frontal
scans in the testing data set. We then modify the training

SELECT
label != NaN

Training data

Data pre-processing

Explicit training
data

Trained model
Predict

Data set
Testing data

Predictions
Legend:

uses both implicit and explicit data
uses explicit data only

Figure 2: The workflow of the machine learning approach.
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Table 2: Distribution of implicit and explicit labels in the
CheXpert data set.
Medical
condition
No Finding

Implicit Explicit
1.0
0
labels labels
89.98% 10.02% 100.00% 0.00%

0.00%

Enlarged Card.
Cardiomegaly
Lung Opacity
Lung Lesion
Edema

79.93%
79.32%
47.28%
94.65%
61.53%

20.07%
20.68%
52.72%
5.35%
38.47%

24.08%
58.44%
89.64 %
76.91%
60.78%

48.26%
24.06%
5.60%
12.46%
24.11%

27.66%
17.50%
4.75%
10.63%
15.11%

Consolidation
Pneunomia
Atelectasis
Pneumotorax
Pleural Effusion
Pleural Other

68.39%
87.64%
69.36%
64.67%
40.37%
97.09%

31.61%
12.36%
30.64%
35.33%
59.63%
2.91%

20.93%
21.87%
48.76%
24.64%
64.70%
54.27%

39.79%
10.14%
1.94%
71.38%
26.57%
4.87%

39.28%
67.99%
49.30%
3.98%
8.73%
40.87%

Fracture

94.54%

5.46%

74.13% 20.60% 5.26%

Support Devices 44.85% 55.15% 94.14%

4.98%

-1.0

0.88%

data set as follows.
We consider uncertain instances as negative
instances because, given a positive prediction of
Cardiomegaly from our model, we want to be as certain
as possible that this prediction is correct and our model
only learns explicit positive labels as such. In the case
of a binary prediction, this handling resulted in the best
performance for Irvin et al. [27]. To obtain the training
set, we first filter it for explicitly labeled instances,
leaving us with 26,407 explicit scans in the training
subset. Of those scans, 61.64% were assigned positive
labels, while 38.36% were assigned negative labels.
Following the common rule of thumb, we then use 10%
of the training data as a validation data set to implement
our early stopping approach and prevent overfitting of
our ML model. This results in 23,767 explicitly labeled
scans for the training data set and 2,640 explicitly
labeled scans for the validation data set. In doing so, our
approach significantly differs from other studies using
the CheXpert data set, which usually map the implicit
data instances to a 0 label (negative finding) [27].
Additionally, we need a data set to generate metrics
and create comparable results to the available literature,
called the benchmark set.
For this, we use the
available CheXpert validation set. Together with the
CheXpert testing set, which is not publicly available, it
is annotated by five board-certified radiologists with a
majority vote [27]. In total, we have 4 subsets of our
original data set: the training set, the testing set, the
validation set, and the benchmark set (not displayed in
Figure 2).

4.2.

Neural network architecture

After pre-processing our data, we now turn to
the training of our ML model on the training data

Figure 3: ROC curves of our trained ML model on the the
benchmark set.

set.
For this, we use the DenseNet-121 neural
network architecture [34], which is widely used
in the computer vision community.
Additionally,
prior research compared different architectures and
discovered that the DenseNet-121 architecture works
best for the CheXpert data set [27]. The DenseNet-121
consists of four dense blocks, which themselves consist
of a convolutional layer followed by a pooling layer. The
novelty introduced by the dense blocks are the direct
connections from one layer to all following layers within
the single dense block. This improves the information
flow between the layers [34].
As we now have decided for a neural network
architecture, we also need to set the hyperparameters,
before we can train our neural network. For most
hyperparameters, we orient ourselves toward prior
research [27]. Specifically, we use the Adam optimizer
with default β-parameters β1 = 0.9 and β2 = 0.999.
Our learning rate is 1 × 10−4 . We keep the input image
size of 320 × 320 pixels. However, as we have fewer
images to train on, we decrease the batch size to 8.
Furthermore, we implement an early stopping with the
validation set to choose the right amount of epochs to
train and prevent overfitting on the data.

4.3.

Evaluation of the neural network

In accordance with the implemented early stopping
approach [35], we evaluate the performance of our
network on the validation set after each training epoch.
Since overfitting occurs if we train for more than 12
epochs, we stop our training after 12 epochs.
When evaluating the trained model with the
benchmark data set, the model performs well with an
area under the curve (AUC) of about 0.81 (see Figure 3),
which is below the AUC of 0.9 reached in the original
CheXpert study [27]. A potential reason for this could
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be the fact that the benchmark data set is relatively
small with only 200 scans and contains a different label
distribution than the training data set. Still, we deem
an AUC of 0.81 to be a value we can work well with, as
our goal is not to improve the already good classification
results of earlier studies but rather achieve a model with
comparable results to be able to test our heuristics on.

5.

Heuristic approach

5.1.

Overview

After training the ML model on explicit instances
only, we can employ the resulting ML model to
classify implicitly labeled data instances on the testing
set. If the classification with the ML model deviates
from the instance’s original label, either the instance
may be mislabeled, or the model provided a wrong
classification. To minimize the likelihood that the ML
model provided us with a wrong classification, or in
other words, to minimize the number of false positives,
we developed a heuristic for the CheXpert data set that
helps us with narrowing down the potentially mislabeled
instances with confidence. We illustrate our heuristic
approach in Figure 4 and describe it in more detail in
the following.

5.2.

Scans of interest

As we later in our heuristic want to identify patients
who potentially have a Cardiomegaly diagnosis later in
their life, we only focus on patients that have at least two
points of diagnosis in our testing set. This leaves us with
25,655 scans containing both implicitly and explicitly
labeled data instances in the testing set. The majority of
patients removed from the testing set have only one scan
provided in the entire data set.
Before we can classify scans of this testing set
and detect potentially mislabeled scans, we need to
transform the neural network output into discrete
classes. By default, our model does not directly
classify an image, but rather predicts a two-dimensional
array whose values add up to 1. The first position

Predictions

of the array states the certainty of our model that an
image has a positive finding for Cardiomegaly, whereas
the second position states the certainty for a negative
finding. To obtain discrete class labels, we need a
threshold that separates positive and negative classes.
A simple approach is to classify a class prediction as
positive once the likelihood for it is predicted to be
higher than the opposite likelihood. That means we
would set the threshold to 0.5 and if the model is more
than 50% certain that the image belongs to a class,
we also predict it as said class. However, this might
not always work in practice. Different types of errors
incur varying opportunity costs in real-world scenarios
[36]. Our approach identifies potentially mislabeled
scans that should be checked by a radiologist and
ideally be relabeled. Currently, one of the relevant
issues for medical training data is the availability of
medical personnel for labeling [10]. Choosing a lower
threshold for predicting an implicit instance as positive
would result in a higher recall but lower precision.
Likewise, choosing a higher threshold would result in a
higher precision, but it would also miss some mislabeled
instance in the data set.
Consequently, we analyze possible thresholds on the
benchmark set and observe that with a threshold value
of 0.7864147 we have no false-positive predictions
on the benchmark set. With this value, we are able
to minimize the false positive predictions, while still
having good results. After setting our threshold based on
the benchmark set, we test our threshold on our testing
data set. We use the explicitly labeled data instances to
assess the performance of our model on the testing set.
Overall, we have 8,600 explicitly labeled data instances
in our testing set. On these explicitly labeled data
instances, we obtain 180 false-positive predictions with
our model, which is a rate of about 2%. Considering our
goal of minimizing the false positive rate, we deem this
to be a good result and, therefore, selected the threshold
accordingly.
The remainder of the testing set consists of implicitly
labeled data instances.
These are interesting for
our heuristics, and we use them to find potentially
mislabeled data instances. In total, there are 17,055

SELECT
prediction = True
AND test_label =
NaN

SELECT
later test_label reﬂects
diagnosis
change

SELECT
change in diagnosis
in same year

Scans of interest

Critical scans

Potentially
erroneous scans

Figure 4: The heuristic approach we follow to identify potentially mislabled instances.
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implicitly labeled data instances on the testing set. Out
of these, our model predicted 1,500 instances (spread
amongst 691 patients) to have a positive finding for
Cardiomegaly while originally having a NaN label on
the testing set. Therefore, these scans are potentially
mislabeled and we further investigate these in our
heuristic. We refer to these as scans of interest.

5.3.

In order to maximize the precision of our approach,
we further filter the acquired scans of interest and only
focus on patients whose indication for Cardiomegaly
changed between their examinations. In total, 662
patients had a change in their Cardiomegaly diagnosis,
resulting in 1,431 potentially mislabeled scans. As these
scans have an even higher likelihood to be mislabeled,
we call these critical scans. Nearly all of the scans of
interest are also critical scans.

5.4.

Potentially erroneous scans

To even further increase the precision of our
heuristic, we now focus on scans where a change in
diagnosis happened within one year and not during the
lifetime of the corresponding patient. Since each scan
comes with a label on the patient’s age at the time of
the scan, we can obtain the time difference between two
scans for a given patient. We refer to the remaining
scans as potentially erroneous scans. This further
increases the likelihood that a scan is mislabeled since
a radiologist explicitly labeled the patient’s scan shortly
after. This leads us to 1,265 potentially erroneous scans
(among 613 patients).

5.5.

(a) Patient 02001
study 18, view 1

Critical scans

Evaluation

To verify the results of our pipeline, we conducted a
blind study with a professional radiologist. Specifically,
we provided the radiologist with 50 X-ray scans that
we asked him to label on a scale from -5 (condition
definitely not present) to 5 (condition certainly present)
for the medical conditions Atelectasis, Cardiomegaly,
Pneumothorax, and Consolidation. Within these 50
scans, 30 were selected from the detected potentially
erroneous scans. Thereby, the 10 scans with the highest
probability were selected by hand and 20 scans were
selected at random out of the remaining potentially
erroneous scans. We picked the other 20 scans randomly
from the other conditions to avoid a bias in the set.
Out of the 50 scans, 34% were assigned a label
of +3 or higher for the presence of Cardiomegaly,
46% were assigned a label of -3 or lower for the
presence of Cardiomegaly, the remaining ones have a

(b) Patient 37546
study 1, view 1

Figure 5: Potentially mislabeled scans as confirmed by a
professional radiologist.

label somewhere in between. In total, the average label
for the presence of Cardiomegaly is -0.66. Just looking
at the 30 potentially erroneous scans, 17 or 56.7% have a
label of at least +3 and only 8 or 26.7% have a value of -3
or lower. Two of the likely mislabeled scans are shown
in Figure 5. Based on the neural network output, these
two had the highest probability of being mislabeled,
and the consulted radiologist confirmed that it is very
likely that the patients suffer from Cardiomegaly. The
remaining values in this set of 30 potentially erroneous
scans are between the two above numbers. The average
label within this set is +1.59.
Furthermore, all but one of the scans with a
radiologist’s label of at least +3 have been from the
detected potentially erroneous scans, while most labels
connoted with -3 or lower are from the randomly
sampled scans. We, therefore, conclude that the
radiologist’s feedback confirms the effectiveness and
precision of our approach in successfully identifying
mislabeled data instances for medical image purposes.

6.
6.1.

Discussion
Principal findings

In this research, we propose a two-staged pipeline
for the identification of potentially mislabeled instances
in a large medical data set. For this, we first introduce
the distinction between explicitly and implicitly
labeled instances, which commonly occur in medical
environments. We train an ML model on a high-quality
subset of explicitly labeled instances and apply this
model to re-classify data instances for which there
was a higher uncertainty regarding the correctness of
their labels. Subsequently, in the second stage of
our pipeline, we develop and apply a heuristic that
considers certain characteristics underlying our data set
to further improve the certainty with which we are
able to identify mislabeled instances. We evaluate
the performance of our proposed system pipeline by
surveying a professional radiologist who manually rated
the likelihood of certain diseases on a set of X-ray scans.
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This evaluation confirms that our approach successfully
identifies mislabeled instances in medical data sets with
high precision.
In total, we found 1,265 potentially erroneous scans
in 17,055 implicit data instances, indicating that about
7.4% of the implicit instances are potentially labeled
incorrectly in the CheXpert data set. Our results,
therefore, slightly exceed error rates of 3% to 5% that
are reported in earlier studies on label quality in public
ML data sets [5, 37]. However, those error rates are
reported on data sets in a broader, general context [38,
39, 37]. Looking at extant research, a variety of possible
reasons for the occurrence of mislabeled instances might
exist for our particular case. First, performing medical
diagnoses is a difficult and error-prone task [40, 41], and
consequently, radiologists might simply have missed a
condition during the examination of some X-ray scans
[42]. Second, the pooling of scans from different
hospitals and patients, as is the case with the CheXpert
data set, might have also resulted in some mislabeled
instances. Under regular circumstances, patients are
checked for a certain condition only and not for the
full range of labels the CheXpert data set provides.
Third, some instances might have been mislabeled due
to inaccuracies in the rule-based label extractor (i.e.,
the condition was present in the text-based radiology
report but not recognized and transferred to the label
file). Toward this end, considering that our error rate
only applies to Cardiomegaly, which is one of several
diseases included in the original CheXpert data set, as
well as our careful selection process and threshold, we
can assume that the total number of incorrectly labeled
scans is even higher.
Different steps in our heuristic reduce the number of
identified mislabeled scans from 1,500 scans of interest
to 1,265 potentially erroneous scans. As such, after
applying our heuristic to filter down the scans and
increase the precision, about 88% of the originally found
scans of interest are also potentially erroneous scans.
This suggests that even by applying only part of our
heuristic, for example by only obtaining scans of interest
and skipping the subsequent filtering steps, our approach
is capable of precisely identifying a fairly large number
of mislabeled instances. One likely reason for this is
the fact that we trained our ML model on high-quality,
explicitly labeled instances only, and therefore our
initially trained model already performs quite well.
Nevertheless, it also shows that by augmenting the first
stage of the presented pipeline with a heuristic that
caters to the specifics of the underlying data set, we were
able to effectively lower the number of instances to be
considered for relabelling.

6.2.

Implications for research and practice

For research, we highlight the effectiveness of
ML-based approaches for the ex-post detection of
mislabeled instances. In particular, we show that
multi-stage pipelines, such as combining ML-based
approaches for the detection of mislabeled instances
with data set-specific heuristics, can be useful for
detecting mislabeled instances more accurately and with
more confidence. This is especially useful in contexts
where expert knowledge is required to (re-)label an
instance and where such experts’ valuable time is better
spent on other tasks (e.g., health care) [10]. We can
present to these experts the data instances which are
most likely to be mislabeled and, thus, a correction can
have the highest influence on improving the data set
and building trustworthy ML-based information systems
with that new data set. Additionally, we introduce the
notion of explicitly and implicitly labeled instances and
emphasize the importance of treating implicitly labeled
instances different from explicitly labeled instances,
even beyond the specific use case that we present
here. Today, most extant research assumes a fixed
label for implicitly labeled data (e.g., [27]), which
potentially impedes performance and the development
of explainable and trustworthy ML-based information
systems. The results of our model training indicate
that even with fewer, but high-quality samples, we
are able to achieve similar prediction results. Based
on our results, researchers should consider correcting
mislabeled instances before publishing research data
sets. If their goal, for example, is to publish a data
set comparable to realistic real-world conditions, it
may be inappropriate to correct mislabeled instances.
If their goal is, however, to foster the development
of trustworthy ML-based information systems for
real-world environments, it may be important to correct
mislabeled instances before publishing the data set.
For practice, our results highlight that practitioners
should critically reflect on the label quality of public and
private data sets that they want to use for supervised ML,
especially in situations where trust in the ML models is
essential. Lastly, our findings suggest that radiologists
occasionally miss a disease when analyzing scans. Our
findings, therefore, also support the deployment of
AI-based medical image analysis systems to augment a
radiologist’s decision in real-time, which may improve
the health outcome for patients.

6.3.

Limitations and future research

We only evaluated our approach on the
Cardiomegaly label and excluded labels representing

Page 1301

other diseases.
With our selective focus on
Cardiomegaly, we may have excluded correlations
with other diseases present in the original study.
Additionally, we were only able to evaluate a subset
of around 30% of the patients present in the data set,
since this was the size of our testing data set. Future
research should therefore also apply our proposed
system pipeline to other diseases in the CheXpert
data set, as well as to other data sets for supervised
ML. For this, potential data sets should have similar
characteristics, such as a temporal dimension and
uncertainty labels. Medical data sets often inherently
exhibit these characteristics, however, our approach
could also be applied to non-medical data sets. In
general, incorporating distinctive data set characteristics
into the analysis could provide a fruitful ground for
further improvements in improving label quality.
Another limitation pertains to the fact that we excluded
implicit scans with the heuristic selection process,
which may have resulted in the loss of some true
positives. However, in doing so, we at the same time
increased the precision of our proposed pipeline and,
therefore, reduced the effort on radiologists, who may
need to reevaluate flagged scans. Nevertheless, future
research should further investigate the symbiosis of
explicitly and implicitly labeled data regarding the
benefits and risks of treating implicitly labeled data
instances differently. Toward this end, other methods
for handling implicit data should be explored, such
as, for example, weighting implicit data instances less
than explicit data instances. Lastly, we compressed
the original X-ray scans for training purposes and may
have lost relevant image information in the process.
We chose this specific resolution to keep our training
process within a reasonable time frame and stay as close
as possible to the original CheXpert study.

7.

Conclusion

In this research, we present a two-staged pipeline
for the identification of potentially mislabeled instances
in medical imaging data sets. Our results reveal that
there are 7.4% of potentially mislabeled instances for
the Cardiomegaly disease in the CheXpert data set,
a data set that has received large attention from the
computer vision research community. In developing the
pipeline that we propose in this paper, we contribute
to the current state of research, especially on label
quality in supervised ML, in two ways. First, we show
that the combination of ML-based approaches for the
identification of labeling errors with data set-specific
heuristic approaches serves to improve the precision
with which labeling errors may be detected. Thus, it

can reduce expert time required to identify mislabeled
instances confidently. Second, we directly contribute
to the CheXpert data set by identifying potentially
mislabeled instances in the data set, thereby improving
the data quality for a data set that is widely used in
research. Our research is particularly interesting for
researchers and practitioners who aim to contribute to
the emerging field of trustworthy artificial intelligence,
as the availability of high-quality data sets is a
fundamental requirement [14].
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